Australis Capital Stock Fundamentals
| AUSAF Stock | USD 0.0001 0.0001 50.00% |
Australis Capital fundamentals help investors to digest information that contributes to Australis Capital's financial success or failures. It also enables traders to predict the movement of Australis Pink Sheet. The fundamental analysis module provides a way to measure Australis Capital's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Australis Capital pink sheet.
Australis |
Australis Capital Company Shares Outstanding Analysis
Australis Capital's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Australis Capital Shares Outstanding | 260.91 M |
Most of Australis Capital's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Australis Capital is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Australis Capital has 260.91 M of shares currently outstending. This is 44.52% higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The shares outstanding for all United States stocks is 54.37% higher than that of the company.
Australis Capital Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Australis Capital's current stock value. Our valuation model uses many indicators to compare Australis Capital value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Australis Capital competition to find correlations between indicators driving Australis Capital's intrinsic value. More Info.Australis Capital is rated third in return on equity category among its peers. It is rated fifth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Australis Capital's earnings, one of the primary drivers of an investment's value.Australis Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Australis Capital's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Australis Capital could also be used in its relative valuation, which is a method of valuing Australis Capital by comparing valuation metrics of similar companies.Australis Capital is currently under evaluation in shares outstanding category among its peers.
Australis Fundamentals
| Return On Equity | -0.92 | |||
| Return On Asset | -0.17 | |||
| Operating Margin | (2.05) % | |||
| Current Valuation | 4.89 M | |||
| Shares Outstanding | 260.91 M | |||
| Shares Owned By Insiders | 28.32 % | |||
| Shares Owned By Institutions | 0.03 % | |||
| Price To Book | 0.40 X | |||
| Price To Sales | 1.24 X | |||
| Revenue | 9.47 M | |||
| Gross Profit | 5.87 M | |||
| EBITDA | (17.68 M) | |||
| Net Income | (50.09 M) | |||
| Cash And Equivalents | 727.69 K | |||
| Total Debt | 2.45 M | |||
| Debt To Equity | 0.05 % | |||
| Current Ratio | 0.69 X | |||
| Book Value Per Share | 0.1 X | |||
| Cash Flow From Operations | (14.17 M) | |||
| Earnings Per Share | (0.05) X | |||
| Number Of Employees | 10 | |||
| Beta | 1.12 | |||
| Market Capitalization | 8.54 M | |||
| Z Score | 1.8 |
About Australis Capital Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Australis Capital's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Australis Capital using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Australis Capital based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.It undertakes cannabis, as well as horticulture projects in the United States, Canada, Denmark Finland, Iceland, Germany, the Netherlands, Bahrein, the United Arab Emirates, Southeast Asia, and Australia, as well as other jurisdictions. AUSTRALIS CAP operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in Australis Pink Sheet
Australis Capital financial ratios help investors to determine whether Australis Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Australis with respect to the benefits of owning Australis Capital security.